0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Investigation | 
Mark Olfson, MD, MPH; Tobias Gerhard, PhD; Cecilia Huang, PhD; et al.
JAMA Psychiatry. 2015;72(12):1172-1181. doi:10.1001/jamapsychiatry.2015.1737.
Includes: Supplemental Content

Original Article |  FREE
Hermann Faller, MD, PhD; Heinrich Bülzebruck, PhD; Peter Drings, MD; et al.
Arch Gen Psychiatry. 1999;56(8):756-762. doi:10.1001/archpsyc.56.8.756.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
Research Letter  | 
Five-Year Survival After Endosonography vs Mediastinoscopy for Mediastinal Nodal Staging of Lung Cancer
Jolanda C. Kuijvenhoven, MD; Daniël A. Korevaar, MD; Kurt G. Tournoy, MD, PhD; et al.
JAMA Oncology
Review  | 
Biomarkers for the Clinical Use of PD-1/PD-L1 Inhibitors in Non–Small-Cell Lung Cancer A Review
Adrian G. Sacher, MD; Leena Gandhi, MD, PhD
JAMA Oncology
Research Letter  | 
Prospective Study of Repeated Biopsy Feasibility and Acquired Resistance at Disease Progression in Patients With Advanced EGFR Mutant Lung Cancer Treated With Erlotinib in a Phase 2 Trial
Amanda J. Redig, MD, PhD; Daniel B. Costa, MD, PhD; Myriam Taibi, BA; et al.
JAMA Oncology
Brief Report  | 
A Quantitative Comparison of Antibodies to Programmed Cell Death 1 Ligand 1
Patricia Gaule, PhD; James W. Smithy, BS; Maria Toki, MD; et al.